Evidence map›Paper›PMID 38673678›Full record

ArticleJournal of clinical medicine2024

Antithrombotic Use Patterns in COVID-19 Patients from Spain: A Real-World Data Study.

Karen Lizzette Ramirez-Cervantes, Salvador Campillo-Morales, Patricia García-Poza, Manuel Quintana-Díaz, Consuelo Huerta-Álvarez

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Karen Lizzette Ramirez-CervantesSpanish Association Against Cancer, Division of Cancer Prevention, C/Teniente Coronel Noreña 30, 28045 Madrid, Spain.ORCID 0000-0001-5083-1978
Salvador Campillo-MoralesPatient Blood Management Research Group, Hospital La Paz Institute for Health Research, 28040 Madrid, Spain.
Patricia García-PozaDivision of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency for Medicines and Medical Devices (AEMPS), C/Campezo n° 1, Edificio 8, 28022 Madrid, Spain.
Manuel Quintana-DíazIntensive Care Unit, Patient Blood Management Research Group, Research Institute of La Paz University Hospital, La Paz University Hospital, 28040 Madrid, Spain.ORCID 0000-0003-4852-4148
Consuelo Huerta-ÁlvarezDepartment of Public Health and Maternity Childcare, Faculty of Medicine, Complutense University of Madrid, Pl. de Ramón y Cajal, s/n, 28040 Madrid, Spain.ORCID 0000-0003-4012-7826
Agencia Española de Medicamentos y Productos Sanitarios · ESAsociación Española Contra el Cáncer · ESHospital La Paz Institute for Health Research · ESHospital Universitario La Paz · ESUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antithrombotics have been widely used to treat and prevent COVID-19-related thrombosis; however, studies on their use at population levels are limited. We aimed to describe antithrombotic use patterns during the pandemic in Spanish primary care and hospital-admitted patients with COVID-19.

Indexed as

COVID-19prescription patternsthrombosisuse rates

Identifiers

PMID38673678
PMCPMC11051525
OpenAlexW4395010455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.